TheraRadar
← Back
Data updated: Mar 29, 2026

HALSEY

Infectious DiseaseMetabolic
Pharma

HALSEY is a pharmaceutical company focused on Infectious Disease, Metabolic.

1963
Since
57
Drugs
-
Trials
648
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Metabolic 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...